News
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...
The U.S. Food and Drug Administration has approved three vaccines for RSV — GSK's Arexvy, Moderna's mRESVIA and Pfizer's ...
The ACG has published new health maintenance recommendations for patients with IBD, which include appropriate vaccinations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results